Form 4: Sotera Health Director Receives Equity Grant

Director Christopher Simon was granted 14,970 restricted stock units as part of the Sotera Health Company 2020 Omnibus Incentive Plan.

Summary

• Director Christopher Simon received a grant of 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock upon vesting.
• The RSUs vest in full on the earlier of the first anniversary of the grant or the date immediately prior to the next annual shareholders meeting.
• Following this transaction, the director's total beneficial ownership is 34,102 shares, consisting of 19,132 shares of common stock and 14,970 RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is subject to the director's continued service with the company.

Future Outlook

The RSUs are expected to vest within one year, subject to continued service as a non-employee director.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant structure follows standard equity compensation practices for publicly traded companies under an Omnibus Incentive Plan.

Stakeholder Impact

• Minor dilution impact upon eventual vesting and settlement of RSUs.

Next Steps

• Vesting of the 14,970 RSUs on the earlier of the first anniversary or the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Director Compensation, Restricted Stock Units, Insider Ownership